Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Lell

Showing results (171-180 of 173) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 173 results.
BMC Medicine|April 19, 2015
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data, Martin A Adjuik, Richard Allan, et al.
The New England Journal of Medicine|October 20, 2011
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children, Selidji Todagbe Agnandji, Bertrand Lell, et al.
The New England Journal of Medicine|November 10, 2012
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants, Selidji Todagbe Agnandji, Bertrand Lell, et al.
Pageof 18

Showing results (171-180 of 173) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 173 results.
BMC Medicine|April 19, 2015
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data, Martin A Adjuik, Richard Allan, et al.
The New England Journal of Medicine|October 20, 2011
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children, Selidji Todagbe Agnandji, Bertrand Lell, et al.
The New England Journal of Medicine|November 10, 2012
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants, Selidji Todagbe Agnandji, Bertrand Lell, et al.
Pageof 18